We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

171 hedge funds and large institutions have $877M invested in Ariad Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 56 increasing their positions, 48 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 30

17% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 48

10% more capital invested

Capital invested by funds: $801M → $877M (+$76.3M)

3% more funds holding

Funds holding: 166 → 171 (+5)

7% more call options, than puts

Call options by funds: $53.1M | Put options by funds: $49.5M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
171
Holders Change
+5
Holders Change %
+3.01%
% of All Funds
4.94%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
36
Increased
56
Reduced
48
Closed
30
Calls
$53.1M
Puts
$49.5M
Net Calls
+$3.61M
Net Calls Change
+$16.2M

Top Buyers

Rank Fund Capital Flow
1
SPC
Slate Path Capital
New York
+$51.6M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$24.7M
3
Renaissance Technologies
Renaissance Technologies
New York
+$17.5M
4
Deutsche Bank
Deutsche Bank
Germany
+$7.73M
5
ARTA
A.R.T. Advisors
New York
+$4.43M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$28.7M
2
CCM
Camber Capital Management
Massachusetts
-$17.5M
3
Franklin Resources
Franklin Resources
California
-$16.7M
4
Barclays
Barclays
United Kingdom
-$14M
5
PC
PointState Capital
New York
-$12.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
CWM
101
Concert Wealth Management
California
$342K +$335K +42,957 New
Public Employees Retirement Association of Colorado
102
Public Employees Retirement Association of Colorado
Colorado
$334K -$195 -25 -0.1%
HW
103
Hancock Whitney
Mississippi
$322K +$312K +40,000 New
AG
104
Aperio Group
California
$295K +$285K +36,549 New
LPL Financial
105
LPL Financial
California
$294K -$87.5K -11,233 -24%
LTFS
106
Ladenburg Thalmann Financial Services
Florida
$289K +$17.9K +2,297 +7%
URS
107
Utah Retirement Systems
Utah
$267K +$1.56K +200 +0.6%
HSBC Holdings
108
HSBC Holdings
United Kingdom
$264K +$255K +32,696 New
BA
109
BlackRock Advisors
Delaware
$262K – – –
QC
110
QCM Cayman
Texas
$258K +$249K +31,953 New
CAM
111
Congress Asset Management
Massachusetts
$242K – – –
DCM
112
Driehaus Capital Management
Illinois
$239K +$122K +15,600 +111%
Parallax Volatility Advisers
113
Parallax Volatility Advisers
California
$239K +$231K +29,682 New
Credit Agricole
114
Credit Agricole
France
$213K +$119K +15,300 +137%
WMSA
115
Weiss Multi-Strategy Advisers
New York
$212K -$776K -99,670 -79%
Bank of Montreal
116
Bank of Montreal
Ontario, Canada
$207K -$32.7K -4,200 -14%
VKH
117
Virtu KCG Holdings
New York
$207K +$200K +25,640 New
MSA
118
Mason Street Advisors
Wisconsin
$170K -$5.06K -650 -3%
AB
119
Amalgamated Bank
New York
$168K -$1.21K -155 -0.7%
DCM
120
Dynamic Capital Management
Jersey
$156K +$150K +19,300 New
Comerica Bank
121
Comerica Bank
Texas
$142K +$1.65K +212 +1%
Prudential Financial
122
Prudential Financial
New Jersey
$120K – – –
ID
123
Integral Derivatives
New York
$119K +$115K +14,784 New
PA
124
Profund Advisors
Maryland
$107K +$18.2K +2,335 +21%
MLICM
125
Metropolitan Life Insurance Company (MetLife)
New York
$102K – – –
3 4
5
6 7

ARIA Hedge Fund Activity: Q1 2014 in Review

171 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2014, worth a combined $877M — up 9.5% from $801M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ARIA positions and 30 closed out — a net gain of 6 holders — while 56 added to existing stakes and 48 trimmed.

The largest buyer was Slate Path Capital, opening a new position worth an estimated $51.6M. The largest seller was Fidelity Investments, cutting an estimated $28.7M.

  • 171 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2014, up from 166 in Q4 2013.
  • Funds reported $877M of Ariad Pharmaceuticals Inc stock for Q1 2014, up 9.5% quarter-over-quarter.
  • 36 funds opened new Ariad Pharmaceuticals Inc positions in Q1 2014 and 30 closed out, a net change of +6 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2014 was Slate Path Capital, an estimated $51.6M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2014 was Fidelity Investments, an estimated $28.7M sold.

Based on aggregated 13F filings for Q1 2014.